Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia.

Item

http://www.wikidata.org/entity/Q38837834

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia.

@en

type

Item

label

Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia.

@en

prefLabel

Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia.

@en

P1476

Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia.

@en

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations

Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines

Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes.

Safety and efficacy of 5-azacytidine treatment in myelodysplastic syndrome patients with moderate and mild renal impairment.

Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes.

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

Azacitidine: a review of its use in the management of myelodysplastic syndromes/acute myeloid leukaemia.

P2888

s40265-016-0585-0

P304

889-900

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40265-016-0585-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lesley J Scott

P577

2016-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1019006317

http://www.w3.org/2001/XMLSchema#string

P698

27193945

http://www.w3.org/2001/XMLSchema#string

P921

leukemia